![](/img/cover-not-exists.png)
Combination of the insulin sensitizer, pioglitazone, and the long-acting GLP-1 human analog, liraglutide, exerts potent synergistic glucose-lowering efficacy in severely diabetic ZDF rats
P. J. Larsen, E. M. Wulff, C. F. Gotfredsen, C. L. Brand, J. Sturis, N. Vrang, L. B. Knudsen, K. LykkegaardVolume:
10
Year:
2008
Language:
english
Pages:
11
DOI:
10.1111/j.1463-1326.2008.00865.x
File:
PDF, 478 KB
english, 2008